How to Buy Theravance Biopharma Stock
Theravance Biopharma Inc
Theravance Biopharma, Inc. , a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia.
Theravance Biopharma stock last closed at $8.62, up 0.29% from the previous day, and has decreased 9.45% in one year. It has overperformed other stocks in the Biotechnology industry by 0.69 percentage points. Theravance Biopharma stock is currently +15.86% from its 52-week low of $7.44, and -20.92% from its 52-week high of $10.90.
As of Apr 17, 2025, there are 49.47M shares of TBPH outstanding. The market value of TBPH is $426.44M. In the last 24 hours, 160,020 TBPH shares were traded.
How to Buy Theravance Biopharma Stock
Wondering how to invest in Theravance Biopharma stock? Here's how.
- Choose where to buy Theravance Biopharma stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Theravance Biopharma stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your payment method and add your info.
- Research Theravance Biopharma stock: The Theravance Biopharma ticker symbol is TBPH. Is Theravance Biopharma stock a good investment? Should you buy shares of TBPH? How do TBPH's underlying business fundamentals look? Do top analysts think Theravance Biopharma is a good buy? Why has TBPH's stock price moved recently? (Hint: Our stock analysis website can help you understand if TBPH is a good stock to buy).
- Make your TBPH purchase: Decide if you will purchase TBPH shares at the current market price or use a limit order to buy TBPH stock at a particular price.
- Get the latest scoop on your TBPH investment: Create a watchlist to track your position in Theravance Biopharma shares.
Step 1: Choose where to buy Theravance Biopharma stock
You will need an online brokerage account in order to access the NASDAQ market and buy TBPH shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal info so you can invest in TBPH today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open a new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on one of the most highly reviewed stock market apps, you need to deposit funds:
Watch the tutorial below to see the process of depositing funds into your new brokerage account.
Step 4: Research Theravance Biopharma stock
Once you have identified the best place to buy Theravance Biopharma stock, it's critical to research their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Overview of key TBPH info
TBPH Due Diligence Score
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on TBPH's stock page.
What is the fair value of TBPH stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge TBPH's fair value.
Using relative valuations methods:
- TBPH could be undervalued based on its P/B ratio of 2.43x, relative to Biotechnology industry P/B ratio of 4.05x
You can do additional valuation research on TBPH's stock here.
TBPH Financial Overview
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the TBPH balance sheet.
- TBPH has $89.19M in cash and short term investments. This is enough to cover its annual cash burn of $11.87M.
- Total TBPH debt is lower than 5 years ago, relative to shareholder equity.
- TBPH has cash burn of 11867000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the TBPH balance sheet.
Failed Health Checks:
- TBPH profit margin has gone up by 0.08 percentage points in the past year, but the company is still unprofitable.
- TBPH has a relatively high debt to equity ratio of 1.02.
Is it a good time to buy Theravance Biopharma stock, according to analysts?
Out of 1 Wall Street analysts who give ratings on TBPH, the consensus analyst rating on TBPH is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Theravance Biopharma stock forecast page.
TBPH Trading Indicators
How are TBPH Revenues/Earnings doing?
Last year, TBPH revenue was $64.38M. During the past 5 year, TBPH's revenue has increased by -2.59% per year. This was slower than the Biotechnology industry average of 44.43%.
You can research TBPH's earnings and revenue performance here.
What are TBPH insiders up to?
Over the last year, executives and large shareholders at TBPH have bought more shares than they have sold.
Rick E. Winningham, CHIEF EXECUTIVE OFFICER of TBPH, was the latest TBPH insider to buy. They bought $20,364.30 worth of TBPH stock on Feb 28, 2025.
Dig into more about who owns TBPH shares here.
Can I get consistent income from TBPH stock?
No, Theravance Biopharma doesn't provide an income stream by paying out dividends.
What do other investors have to say about TBPH?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your TBPH purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, use a limit order.
Press the Open button and eToro will execute the order.
If you require additional help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your TBPH investment
Now that you own some TBPH stock, you'll want to stay up-to-date on your new investment.
Put TBPH on a watchlist to keep tabs on your TBPH stock.
TBPH Feed
How to Buy Stock in Theravance Biopharma
To summarize, here are the 6 steps to buy Theravance Biopharma stock:
- Choose where to buy Theravance Biopharma stock
- Open your brokerage account
- Deposit funds into your investment account
- Research Theravance Biopharma stock
- Make your TBPH purchase
- Get the latest scoop on your TBPH investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your new investment in Theravance Biopharma, create a watchlist on WallStreetZen today.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.